Use of the site of subcutaneous insulin for glucose determination in patients with Type 1 Diabetes.

被引：0
|
作者：
Regittnig, Werner [1 ]
Lindpointner, Stefan [1 ]
Korsatko, Stefan [1 ]
Koehler, Gerd [1 ]
Kaidar, Ruthy [2 ]
Yodfat, Ofer [2 ]
Koehler, Hans [3 ]
Ellmerer, Martin [1 ]
Pieber, Thomas [1 ,3 ]
机构：
[1] Med Univ Graz, Univ Klin Innere Med, Graz, Austria
[2] Medingo Ltd, Yoqneam Illit, Israel
[3] Joanneum Res GmbH, Inst Med Syst Tech & Gesundheitsmanagement, Graz, Austria
来源：
WIENER KLINISCHE WOCHENSCHRIFT | 2009年 / 121卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S22 / S22
页数：1
相关论文
共 50 条
  • [1] Use of the Site of Subcutaneous Insulin Administration for the Measurement of Glucose in Patients With Type 1 Diabetes
    Lindpointner, Stefan
    Korsatko, Stefan
    Koehler, Gerd
    Koehler, Hans
    Schaller, Roland
    Kaidar, Ruthy
    Yodfat, Ofer
    Schaupp, Lukas
    Ellmerer, Martin
    Pieber, Thomas R.
    Regittnig, Werner
    DIABETES CARE, 2010, 33 (03) : 595 - 601
  • [2] Glucose concentrations at the site of subcutaneous insulin delivery in patients with type 1 diabetes
    Regittnig, W.
    Lindpointner, S.
    Korsatko, S.
    Koehler, G.
    Kaidar, R.
    Yodfat, O.
    Koehler, H.
    Ellmerer, M.
    Pieber, T. R.
    DIABETOLOGIA, 2009, 52 : S42 - S42
  • [3] TEMPORARY USE OF GLUCOSE SENSORS IN TYPE 1 DIABETES PATIENTS ON CONTINUOUS SUBCUTANEOUS INSULIN INFUSION
    Zivkovic, M.
    Petrovski, G.
    Stratrova, S. Shubeska
    DIABETES TECHNOLOGY & THERAPEUTICS, 2020, 22 : A147 - A147
  • [4] POPULATION PHARMACOKINETICS OF INTRADERMAL VS. SUBCUTANEOUS INSULIN DELIVERY IN PATIENTS WITH TYPE 1 DIABETES.
    Yu, T.
    Sinha, M.
    Hillard, M.
    Sherwin, C.
    Russell, S.
    Spigarelli, M.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2015, 97 : S48 - S49
  • [5] CONTINUOUS SUBCUTANEOUS INSULIN INFUSION IS ASSOCIATED WITH BETTER NAFLD INDICES IN PATIENTS WITH TYPE 1 DIABETES.
    Gianfrancesco, S.
    Raso, E.
    Bozzetto, L.
    Boccia, R.
    Della Pepa, G.
    Scarpelli, G.
    Petrosino, C.
    Annuzzi, G.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2022, 24 : A173 - A173
  • [6] Benefits of continuous subcutaneous insulin infusion in type 1 diabetes. Is there any doubt?
    Asuncion Martinez-Brocca, Maria
    ENDOCRINOLOGIA Y NUTRICION, 2016, 63 (03): : 103 - 105
  • [7] Focal vitiligo related to subcutaneous insulin lispro infusion in type 1 diabetes.
    Carey, JD
    Burge, MR
    JOURNAL OF INVESTIGATIVE MEDICINE, 2003, 51 : S143 - S143
  • [8] Insulin aspart in pediatric and adolescent patients with type 1 diabetes.
    Tsalikian, E
    DIABETOLOGIA, 2000, 43 : A200 - A200
  • [9] Evaluation of Microdialysis-based glucose monitoring in blood and subcutaneous adipose tissue in patients with Type 1 Diabetes.
    Mader, Julia
    Feichtner, Franz
    Bock, Gerlies
    Koehler, Gerd
    Schaller, Roland
    Plank, Johannes
    Pieber, Thomas
    Ellmerer, Martin
    WIENER KLINISCHE WOCHENSCHRIFT, 2009, 121 : S20 - S20
  • [10] Use and Discontinuation of Continuous Subcutaneous Insulin Infusion and Continuous Glucose Monitoring in Paediatric Patients with Type 1 Diabetes: Rates and Causes
    Shalitin, Shlomit
    HORMONE RESEARCH IN PAEDIATRICS, 2016, 86 : 23 - 23
12345